Eton Pharmaceuticals Q4 Earnings Call Highlights
Eton posted GAAP net income of $1.5 million for the quarter, compared with a GAAP net loss of $0.6 million in the year-ago period. On a non-GAAP basis, net income was $5.4 million versus $0.7 million a year earlier. Adjusted EBITDA was $6.2 million, or 29% of revenue, up from $2.1 million, or 18%, in the prior-year quarter.Adjusted gross profit was $15.5 million, or 73% of revenue, compared with $6.8 million, or 59%, a year earlier. Gruber attributed the improvement to favorable product mix and manufacturin ...